The family members of HBsAg camers have an increased risk of hepatitis B virus (HBV) infection. 214 subjects from 98 families with no HBV markers were randomized to receive hepatitis B vaccine: HEVAC B (Institute Pasteur) or GCC VAC (Green Cross Corporation) at 0, 1, and 5 months. Of those who compl
In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine
β Scribed by Tse Wen Chang; Esteban Celis; Richard W. Miller; Vincent R. Zurawski Jr.; Patrick C. Kung
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 712 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in uitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in uitro proliferative response could be augmented by incubating the cells with HBsAg and supernatants of activated T cells for 2 weeks or longer. After 7 to 10 days, in vitro stimulation with antigen, PBMs (1 x lo8) could yield 5 to 15 HBsAg-specific antibody-secreting plaqueforming cells. The antibody to HBsAg produced in vitro was greatly increased in cultures that contained antigen-specific B cells enriched by panning with HBsAg-coated plates and a T cell growth factor-dependent, HBsAg-specific autologous T cell line. The results indicate that HBsAgspecific B and T cells are present, although at low frequencies, in the circulation of hepatitis B vaccinees.
Hepatitis B still remains the most serious infectious liver disease (1, 2). Contributing to this problem is that some individuals fail to mount an effective immune response to hepatitis B virus (HBV) infection and become chronic carriers of the virus (3). It is important to study how the various components of the immune system of normal individuals and HBV-bearing patients respond to the virus and its components. Such studies will help in understanding the pathology of hepatitis B and improving prevention methods.
The induction of most immune responses are known to involve complicated interactions between immunocyte subsets and regulatory factors. In recent years, the studies on the regulation of immune responses have been advanced greatly by analyzing responses of immunocytes under defined conditions in uitro (e.g., 4-6). Of interest is to examine in the in uitro systems whether the variation in the ability of individuals to respond to HBV infection lies in differences in certain regulatory mechanisms. The studies of Chisari et al. (7, 8), Alexander et al. (9) and Mondelli et al. (10) on the analysis of the involvement of cytotoxic and suppressor T cells in hepatitis B are excellent examples of these in uitro studies.
Because the production of antibodies against HBsAg plays a major role in the immune response against HBV ~
π SIMILAR VOLUMES
After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at
## Abstract The reactivity of peripheral blood lymphocytes from patients with advanced malignancy was assessed by mitogenβinduced stimulation of protein synthesis as measured by ^3^Hβleucine incorporation. It was confirmed that the lymphocyte response of patients was depressed. Furthermore, the lym
Previous reports have shown, using fluorescent probes conjugated to the organism, that Mycoplasma fermentans fuses with about 12% of peripheral blood lymphocytes. However, no lymphocyte subset was specified. To elucidate the specific subset of lymphocytes involved, we developed a threecolor flow cyt